UMR_S949, INSERM, Strasbourg, France.
Etablissement Français du Sang-Alsace (EFS-Alsace), Strasbourg, France.
J Thromb Haemost. 2016 Jun;14(6):1255-67. doi: 10.1111/jth.13335. Epub 2016 May 21.
Essentials Role of platelets in immunological transfusion-related acute lung injury (TRALI) is debated. Immunological TRALI was tested in mice exhibiting severe thrombocytopenia or platelet dysfunction. Platelets are required to prevent lung hemorrhage but not edema formation and respiratory distress. Platelets are dispensable for the initiation and development of TRALI.
Background Transfusion-related acute lung injury (TRALI) is a serious transfusion-related complication. Previous conflicting studies have indicated that platelets are either crucial or dispensable for TRALI. Objectives To evaluate the role of platelets in major histocompatibility complex (MHC) I-induced-TRALI. Methods Antibody-mediated TRALI was experimentally induced in mice by lipopolysaccharide priming followed by the administration of an anti-MHC I mAb. Results TRALI was tested in the context of severe thrombocytopenia provoked by the administration of diphtheria toxin (DT) in transgenic iDTR mice selectively expressing DT receptor in megakaryocytes. The pathologic responses occurring within the first 10 min following the injection of the anti-MHC I mAb, i.e. the severity of lung edema and the drop in aortic blood oxygenation, were similar in severely thrombocytopenic DT-iDTR and control mice. At later times, mortality was nevertheless increased in DT-iDTR mice, owing to lung hemorrhages. When less severe thrombocytopenia was induced with an antiplatelet mAb, TRALI started and developed similarly as in control mice, but hemorrhages were absent. Furthermore, when platelet functions were defective because of administration of aspirin or clopidogrel, or because of glycoprotein (GP)IIbIIIa deficiency, TRALI still developed but no lung hemorrhages were observed. In contrast, when GPVI was immunodepleted, TRALI still occurred, but was occasionally accompanied by hemorrhages. Conclusions Platelets are dispensable for the initiation and development of MHC I-induced TRALI. Although they do not protect against the disruption of the vascular endothelial cell barrier and the subsequent plasma leakage and edema formation, platelets are essential to prevent more serious damage resulting in hemorrhages in alveoli.
探讨血小板在免疫性输血相关急性肺损伤(TRALI)中的作用。方法:用脂多糖预处理小鼠,然后给予抗 MHC I mAb,建立免疫性 TRALI 模型。结果:在严重血小板减少症(由转染 iDTR 小鼠中的白喉毒素(DT)引起)的情况下测试了 TRALI。在注射抗 MHC I mAb 后 10 分钟内发生的病理反应,即肺水肿的严重程度和主动脉血氧饱和度下降,在严重血小板减少症的 DT-iDTR 和对照小鼠中相似。然而,在稍后的时间点,由于肺出血,DT-iDTR 小鼠的死亡率增加。当用抗血小板 mAb 引起较轻的血小板减少症时,TRALI 与对照小鼠一样开始和发展,但没有出血。此外,当由于给予阿司匹林或氯吡格雷或由于糖蛋白(GP)IIbIIIa 缺乏导致血小板功能缺陷时,仍发生 TRALI,但未观察到肺出血。相比之下,当 GPVI 被免疫耗竭时,TRALI 仍会发生,但偶尔伴有出血。结论:血小板对于 MHC I 诱导的 TRALI 的发生和发展是可有可无的。尽管它们不能防止血管内皮细胞屏障的破坏以及随后的血浆渗漏和水肿形成,但血小板对于防止肺泡内更严重的出血损伤是必不可少的。